<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: <z:hpo ids='HP_0000822'>Hypertension</z:hpo> is a primary aggravating factor in <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>An <z:hpo ids='HP_0011009'>acute</z:hpo> rise in blood pressure (BP) at the time of a <z:hpo ids='HP_0001297'>stroke</z:hpo> may be harmful to the brain in a hypertensive subject because both cerebral vascular structure and function are altered by <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Muscarinic M1 receptors are concerned with memory and learning </plain></SENT>
<SENT sid="3" pm="."><plain>We aimed to evaluate the effect of controlling BP in hypertensive subjects at the time of <z:hpo ids='HP_0001297'>stroke</z:hpo> with a biochemical index of brain damage </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: We gave a single dose of either the <z:chebi fb="0" ids="35674">antihypertensive</z:chebi> alpha-blocker phentolamine (2 mg/kg IP) or the calcium <z:chebi fb="68" ids="48706">antagonist</z:chebi> nicardipine (2 mg/kg IP) at the start of bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> to spontaneously hypertensive rats undergoing 3 hours of <z:e sem="disease" ids="C0022118" disease_type="Disease or Syndrome" abbrv="">transient ischemia</z:e>; we measured the time course of mean BP (MBP) and changes in the M1 receptor and its <z:chebi fb="2" ids="33699">mRNA</z:chebi> in three brain regions 2 weeks after the <z:e sem="disease" ids="C0022118" disease_type="Disease or Syndrome" abbrv="">transient ischemia</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Administration of phentolamine or nicardipine not only significantly suppressed the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced rise of MBP, it actually decreased MBP during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>In an ischemic control group, M1 receptor binding decreased in the frontal cortex and M1 receptor <z:chebi fb="2" ids="33699">mRNA</z:chebi> increased in the hippocampus 2 weeks after the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>In contrast, both phentolamine- and nicardipine-treated ischemic rats showed no changes in either index compared with sham-operated controls </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Controlling BP during an ischemic insult attenuates <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced damage of M1 receptors in the brain of spontaneously hypertensive rats </plain></SENT>
<SENT sid="9" pm="."><plain>These results suggest that a rapid intensive increase of BP at the time of a <z:hpo ids='HP_0001297'>stroke</z:hpo> may exacerbate brain damage in hypertensive individuals </plain></SENT>
</text></document>